вторник, 26 июля 2016 г.

Weekly Research Analysts' Ratings Changes for Puma Biotechnology

Weekly Research Analysts' Ratings Changes for Puma Biotechnology


They now have a $46.00 price target on the stock, up previously from $36.00. 7/12/2016 - Puma Biotechnology was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.



from Biotech News